Pharmaceuticals solutions
Marketing Attribution for Pharmaceuticals
Beryl Analytics has spent the better part of a decade building marketing attribution systems for pharma & biotech across New Zealand and Australia. We know which patterns generalise, which break, and how to ship value in weeks rather than quarters.
Why pharmaceuticals teams choose Beryl Analytics for marketing attribution
- Deep-domain models. Every marketing attribution model we build is tuned to the realities of pharma & biotech — not the synthetic benchmarks you see in vendor pitches.
- Production-ready, not throwaway. We ship pipelines, monitoring, alerting, and runbooks — the boring stuff that decides whether the system survives contact with reality.
- Operator-first design. Insights live inside the tools your team already uses, with thresholds and ownership matched to how decisions actually get made.
- Governance built in. Lineage, explainability, and access controls aren't an afterthought — they're scoped from day one and signed off with your security team.
- Outcomes measured in dollars. We track impact in revenue, cost avoided, or risk reduced — never in dashboard counts.
How we deliver marketing attribution engagements
- 01
Discovery (week 1-2)
We meet your operators, map data sources, and pressure-test the business case. Half the value is sometimes in killing the wrong initiative and reframing the right one.
- 02
Pilot build (week 3-6)
One vertical slice end-to-end: ingest, model, dashboard, monitoring. Real data, real users, measurable result before we expand.
- 03
Productionise (week 7-12)
Hardening, governance, lineage, runbooks, observability. Pair-programmed with your team so they own it by handover.
- 04
Scale & evolve
Expansion into adjacent use cases, retraining cadence, model performance reviews, and a roadmap that compounds.
Frequently asked questions about Marketing Attribution for Pharmaceuticals
How long does a typical Marketing Attribution engagement take for a pharmaceuticals business?
Most marketing attribution projects for pharma & biotech land a working production slice within 4-6 weeks, then harden and expand over the following 8-12 weeks. Larger pharmaceuticals programmes that touch multiple business units take 4-6 months end-to-end.
What data do you need to start a Marketing Attribution project in pharmaceuticals?
Minimum viable inputs are 12-18 months of historical transactional or operational data, basic entity reference tables, and access to the systems that will consume the output. We can work with messy data — cleaning is part of the engagement.
Can Beryl Analytics integrate marketing attribution with our existing pharma & biotech systems?
Yes. We're tool-agnostic and have integrated with Snowflake, BigQuery, Databricks, Salesforce, SAP, Oracle, custom in-house platforms, and dozens of pharmaceuticals-specific systems. Insights surface inside the tools your operators already use.
How do you measure success on a Marketing Attribution engagement?
Before we model anything, we agree the business decision the output will change and the dollar metric we're targeting — revenue lifted, cost avoided, or risk reduced. Marketing Attribution engagements in pharmaceuticals typically return 4-12x within the first year.
Do you work with pharmaceuticals businesses outside major NZ and AU cities?
Yes. We deliver remotely across New Zealand and Australia and visit on-site for discovery, key workshops, and go-live. Distance is not a blocker — many of our highest-impact marketing attribution engagements have been with regional pharma & biotech.